Company intelligence / Profile preview

joimax

Karlsruhe, Baden-Württemberg, Germanyjoimax.com ↗

Ownership: Private
Employees: ~102
Development stage: Commercial

Overview

joimax’s minimally invasive endoscopic spine surgery systems are commercially available worldwide. Their devices have been used in thousands of procedures for herniated discs, spinal stenosis, facet and sacroiliac joint syndromes, and spinal stabilization. The company supports its products with extensive physician education programs accredited by leading institutions. Clinical results are supported by nearly five thousand published papers on endoscopic spine surgery using such technologies.

Therapeutic areas: RheumatologyNeurology
Modalities: Device (Endoscopic surgical systems)Non-pharmacological therapy (Minimally invasive surgery)
Industry: Surgical Medical Devices

Partnerships

NAMSA – strategic partnership for reimbursement support in the US market as of July 2021.

Beyond the preview

Go deeper on joimax.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on joimax.

Explore the full profile